Skip to content

Key AMR Indicators

Antimicrobial Resistance (AMR)

Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%)

2023

Proportion of bloodstream infection due to Escherichia coli resistant to third-generation cephalosporins (%)

2023

Total consumption of antibacterials expressed as Defined Daily Doses (DDD) per 1000 inhabitants per day

2023

Antibacterial consumption: Target ≥70% of total antibiotic consumption being Access group antibiotics

2023

Pattern of antibiotic consumption at national level (Percent (%) of relative consumption by AWaRe classification)

2023

Tracking AMR Country Self-Assessment Survey (TrACSS)

Country progress with development of a national action plan on AMR

2024
A - No national AMR action plan or plan under development.
B - National AMR action plan developed.
C - National AMR action plan approved by government and is being implemented.
D - National AMR action plan has costed and budgeted operational plan and has monitoring mechanism in place.
E - Financial provision for the National AMR action plan implementation is included in the national plans and budgets.

Multi-sector and One Health collaboration/coordination

2024
A - No formal multi-sectoral governance or coordination mechanism on AMR exists.
B - Multi-sectoral coordination mechanism on AMR established with Government leadership.
C - Formalized Multisector coordination mechanism with technical working groups established with clear terms of reference, regular meetings, and funding for working group(s) with activities and reporting/accountability arrangements defined.
D - Joint working on issues including agreement on common objectives.
E - Integrated approaches used to implement the national AMR action plan with relevant data and lessons learned from all sectors used to adapt implementation of the action plan.

Raising awareness and understanding of AMR risks and response

2024
A - No awareness-raising activities on risks of antimicrobial resistance.
B - Some activities to raise awareness about risks of antimicrobial resistance and actions that address it.
C - Some awareness activities at local and/or sub-national level about risks of antimicrobial resistance and actions to address it, targeting some but not all relevant stakeholders, based on stakeholder analysis.
D - Nationwide, government-supported antimicrobial resistance awareness raising campaign targeting all or the majority of priority stakeholder groups, , utilizing targeted messaging accordingly within sectors.
E - Routine Targeted, nationwide government-supported campaign implemented to raise awareness of priority stakeholders across sectors, with regular monitoring.

Training and professional education on AMR in the human health sector

2024
A - No training for human health workers on AMR.
B - Ad hoc AMR training courses in some human health related disciplines.
C - AMR is covered in 1) some pre-service training and in 2) some in-service training or other continuing professional development (CPD) for human health workers.
D - AMR is covered in pre-service training for all relevant cadres. In-service training or other CPD covering AMR is available for all types of human health workers nationwide.
E - AMR is systematically and formally incorporated in pre-service training curricula for all relevant human health cadres. In-service training or other CPD on AMR is taken up by relevant groups for human health nationwide, in public and private sectors.

Legislation

Country has laws or regulations on prescription and sale of antimicrobials, for human use

2024
Source: TrACSS Country Reports

Country has laws or regulations on prescription and sale of antimicrobials for aquatic animals

2024
Source: TrACSS Country Reports

Country has laws or regulations on prescription and sale of antimicrobials for terrestrial animal use

2024
Source: TrACSS Country Reports

Country has legislation or regulations to prevent contamination of the environment with antimicrobials-antimicrobial compounds

2024
Source: TrACSS Country Reports

Health Service Access

Universal health coverage (UHC) service coverage index

2021

Metadata

Copyright and licensing

Copyright

Attribution 4.0 International (CC BY 4.0)

License

The World Health Organization (“WHO”) encourages public access and use of the data that it collects and publishes on its web site data.who.int. The data are organized in datasets and made available in machine-readable format (“Datasets”). The Datasets have been compiled from data provided by WHO’s Member States under the WHO policy on the use and sharing of data collected by WHO in Member States outside the context of public health emergencies.

Use of the data derived from the Datasets, which may appear in formats such as tables and charts, is also subject to these Terms and Conditions. Datasets may include data describing the Dataset called “Metadata”. If any datasets are credited to a source other than WHO, then those materials are not covered by these Terms and Conditions, and permission should be sought from the source provided. You are responsible for determining if this is the case, and if so, you are responsible for obtaining any necessary permission from the sources indicated. The risk of claims resulting from infringement of any third-party-owned component in the materials rests solely with you.

You may use our application programming interfaces (“APIs”) to facilitate access to the Datasets, whether through a separate web site or through another type of software application. By using the Datasets or any presentations of data derived from them, or by using our APIs in connection with the Datasets, you agree to be bound by these Terms and Conditions, as may be amended from time to time by WHO at its sole discretion.

Unless specifically indicated otherwise, these Datasets are provided to you under a Creative Commons Attribution 4.0 International License (CC BY 4.0), with the additional terms below. The basic terms applicable to the CC BY 4.0 license may be accessed here. By downloading or using the Datasets, you agree to comply with the terms of the CC BY 4.0 license, as well as the following mandatory and binding addition:

Any dispute relating to the interpretation or application of this license shall, unless amicably settled, be subject to conciliation. In the event of failure of the latter, the dispute shall be settled by arbitration. The arbitration shall be conducted in accordance with the modalities to be agreed upon by the parties or, in the absence of agreement, with the UNCITRAL Arbitration Rules. The parties shall accept the arbitral award as final.

Permission typePublicly accessible
Prohibited uses

You shall not attempt to de-anonymise the Datasets or use the Datasets in a manner that falsifies or misrepresents their content.

You shall not, in connection with your use of the Datasets published on data.who.int, state or imply that WHO endorses, or is affiliated with, you, or that WHO endorses your use of data.who.int, or any content, output, or analysis resulting from or related to the data.who.int, or any entity, organization, company, product or services.

Citation

World Health Organization 2023 data.who.int, WHO Coronavirus (COVID-19) dashboard > More resources [Dashboard]. https://data.who.int/dashboards/covid19/more-resources

Disclaimer

WHO reserves the right at any time and from time to time to modify or discontinue, temporarily or permanently, the Datasets, or any means of accessing or utilizing the Datasets with or without prior notice to you.

Maps
The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of WHO concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement.

All references to Kosovo should be understood to be in the context of the United Nations Security Council resolution 1244 (1999).

A dispute exists between the Governments of Argentina and the United Kingdom of Great Britain and Northern Ireland concerning sovereignty over the Falkland Islands (Malvinas).

The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by WHO in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.

All reasonable precautions have been taken by WHO to verify the accuracy of the Datasets. However, the Datasets are being provided without warranty of any kind, either expressed or implied. You will be solely responsible for your use of the Datasets. In no event shall WHO be liable for any damages arising from such use.

For full disclaimers, terms of use and your indemnification of WHO, please visit Terms and Conditions.